Клеточные и молекулярные механизмы патогенеза иммуновоспалительных ревматических заболеваний. Марат Зиявдинович Саидов

анатомия и патогенез коллагеновых болезней. Медгиз. 1963 г. 323 с.

      14. Эйнгрон А. Г. Патологическая анатомия и патологическая физиология. М. Медицина, 1983. с.304.

      15. Alam J., Yong C.K, Choi Y. Potential role of bacterial infection in autoimmune diseases: a new aspect of molecular mimicry. Immune Network, 2014, Vol.14, no 1, pp. 7–13. doi: 10.4110/in.2014.14.1.7.

      16. Alsina L., Israelsson E., Altman M. C., Dang K. K., Ghandil P., Chaussabel D. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4. Nat. Immunol., 2014, Vol. 15, no. 12, pp.1134–1142. doi: 10.1038/ni.3028.

      17. Angiolillo A. L., Kanegane H., Sgadari C., Reaman G. H., Tosato G. Interleukin-15 promotes angiogenesis in vivo. Biochem. Biophys. Res. Commu… 1997, Vol. 233, no.1, pp. 231–237. doi: 10.1006/bbrc.1997.6435.

      18. Arai M., Ikawa Y., Chujo S., Hamaguchi Y., Ishida W., Hasegawa M., Mukaida N., Fujimoto M., Takehara K. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis. J. Dermatol. Sci., 2013, Vol. 69, no.3, pp. 250–258. doi: 10.1016/j.jdermsci.2012.10.010.

      19. Auerbach W., Auerbach R. Angiogenesis inhibition: a review. Pharmac. Ther., 1994, Vol. 63, no. 3, pp. 265–311. doi: 10.1016/0163–7258(94)90027–2.

      20. Bachem A., Hartung E., Guttler S., Mora A., Zhou X…Kroczek A. Expression of XCR1 characterizes the Batf3-dependent lineage of dendritic cells capable of antigen cross-presentation. Front. Immunol., 2012, Vol. 3, Article 214.

      doi: 10.3389/fimmu.2012.00214. eCollection 2.

      21. Banchereau J., Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity, 2006, Vol. 25, no.3, pp.383–392. doi: 10.1016/j.immuni.2006.08.010.

      22. Banchereau R., Cepika A. M., Banchereau J., Pascual V. Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics. Annu. Rev. Immunol., 2017, Vol. 35, pp.337–370. doi: 10.1146/annurev-immunol-051116–052225.

      23. Barkauskaite V., Ek M., Popovic K., Harris H. E., Wahren-Herlenius M., Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus, 2007, Vol. 16, no. 10, pp. 794–802. doi.org/10.1177/0961203307081895.

      24. Baumann I., Kolowos W., Voll R. E., Manger B., Gaipl U., Neuhuber W. L. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum., 2002, Vol. 46, no.1, pp.191–201. doi: 10.1002/1529- 0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K.

      25. Blanco P., Palucka A. K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science, 2001, Vol. 294, pp.1540–1543. doi: 10.1126/science.1064890.

      26. Blander J. M. Regulation of the Cell Biology of Antigen Cross-Presentation. Annu. Rev. Immunol., 2018, Vol.36, pp.717–753. https://doi.org/10.1146/annurev-immunol-041015–055523.

      27. Blissett A. R., Garbellini D., Calomeni E. P., Mihai C., Elton T. S., Agarwai G. Regulation of Collagen Fibrillogenesis by Cell-surface Expression of Kinase Dead DDR2. J. Mol. Biol., 2009, Vol. 385, 902–911 doi:10.1016/j.jmb.2008.10.060.

      28. Blokland L. M., Hillen M. R., Kruize A. A., Meller S., Homey B., Smithson G. M. … van Roon J.. Increased CCL25 and T helper cells expressing CCR9 in the salivar glands of patients with primary sjogren’s syndrome: potential new axis in lymphoid neogenesis. Arthr. Rheumatol., 2017, Vol. 69, no.10, pp.:2038–2051. doi: 10.1002/art. 40182.

      29. Braga T. T., Agudelo J. S., Camara N. O. Macrophages during the fibrotic process: M2 as friend and foe. Front Immunol., 2015, Vol. 6, Article 602. doi: 10.3389/fimmu.2015.00602.

      30. Breitfeld D., Ohl L., Kremmer E., Ellwart J., Sallusto F., Lipp M. Forster R. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med., 2000, Vol. 192, no.11, pp.1545–1552. doi: 10.1084/jem.192.11.1545.

      31. Bresnihan B, Pontifex E, Thurlings RM, Vinkenoog M, Gabalawy H, Fearon U…Tak P. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J. Rheumatol., 2009, Vol.36, no. 8, pp.1800–1802. doi:10.3899/jrheum.090348.

      32. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D., Weinrauch Y., Zychlinsky A.. Neutrophil extracellular traps kill bacteria. Science, 2004, Vol. 303, pp. 1532–1535. doi: 10.1126/science.1092385.

      33. Burrage P. S., Mix K. S., Brinckerhoff C. E. Matrix metalloproteinases: role in arthritis. Front Biosci., 2006, Vo l. 11, no. 1, pp.529–543. doi: 10.2741/1817.

      34. Canna S. W., de Jesus A. A., Gouni S., Brooks S. R., Marrero B…. Golbdach-Mansky R. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat. Genet., 2014, Vol. 46, no.10, pp.1140–1146. doi: 10.1038/ng.3089.

      35. Carmona-Rivera C., Zhao W., Yalavarthi, S., Kaplan, M. J. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann. Rheum., Dis. 2015, Vol.74, no.7, pp. 1417–1424. doi: 10.1136/annrheumdis-2013–204837.

      36. Carulli M. T., Ong V. H., Ponticos M., Shiwen X., Abraham D. J., Black C. V., Denton C. P. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation. Arthritis Rheum., 2005, Vol. 52, no12, pp. 3772–3782. doi: 10.1002/art.21396.

      37. Casciola-Rosen L. A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med., 1994, Vol. 179, no.4, pp.1317–1330. doi: 10.1084/jem.179.4.1317.

      38. Chang A., Henderson S. G., Brandt D., Liu N., Guttikonda R., Hsieh C…Clark R. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J. Immunol., 2011, Vol. 186, no.3, pp.1849–1860. doi: 10.4049/jimmunol.1001983.

      39. Christensen S. R., Shupe J., Nickerson K., Kashgarian M., Flavell R. A., Shlomchik M. J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006. Vol. 25, no.3, pp.417–428. doi: 10.1016/j.immuni.2006.07.013.

      40. Crawford Y., Kasman I., Yu L. Zhong C., Wu X., Modrusan Z., Kaminker J., Ferrara N. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell, 2009, Vol.15, no.1, pp.21–34. doi: 10.1016/j.ccr.2008.12.004.

      41. Crosby J. R., Tappan K. A., Seifert R. A., Bowen-Pope D. F. Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptor-beta expression for participation in reactive connective tissue formation in adults but not during development. Am. J. Pathol., 1999, Vol. 154, pp. 1315–1321.

      42. Crotty S. Follicular helper CD4 T cells (TFH). Ann Rev Immunol., 2011, Vol. 29, pp. 621–663. doi: 10.1146/annurev-immunol-031210–101400.

      43. Crow Y. J. Type I interferonopathies: a novel set of inborn errors of immunity. Ann. N. Y. Acad. Sci., 2011; 1238(1), pp.91–98. doi: 10.1111/j.1749–6632.2011.06220.x.

      44. Darrah